Financials
Financial year 2025
Diagnosecentrum Noord-Limburg from Lommel, company number BE0449839082, closed financial year 2025 with a result of € 230,370 after tax. For that financial year Diagnosecentrum Noord-Limburg recorded a gross margin of € 2.8 million and equity of € 5.1 million. Compared with financial year 2024, the result moved from € 171,225 to € 230,370. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 5.1 million
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 230,370
▲ 35% vs 2024
Profit after tax over the fiscal year.
€ 666,568
▲ 122% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.1 million.
People and assets in 2025
25.5
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.7 million
▲ 11% vs 2024
€ 67,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 49,563
▲ 12% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 624,218
▼ 22% vs 2024
€ 120,222 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 168,910
▲ 126% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 326,137
▲ 23% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 2,205,257 | € 2,532,717 | € 2,550,242 | € 2,763,733 | ▲ 8% |
| Profit after taxes | € 39,606 | € 330,460 | € 171,225 | € 230,370 | ▲ 35% |
| Equity | € 5,002,714 | € 5,145,013 | € 5,019,875 | € 5,089,473 | ▲ 1% |
| Total debts | € 1,958,512 | € 2,028,838 | € 2,046,896 | € 1,486,290 | ▼ 27% |
| Cash | € 117,075 | € 380,654 | € 300,213 | € 666,568 | ▲ 122% |
| Land & buildings | € 3,273,641 | € 3,064,883 | € 2,872,175 | € 2,697,281 | ▼ 6% |
| Retained profit | € 3,201,187 | € 3,434,228 | € 2,954,552 | € 3,109,314 | ▲ 5% |
| Bank debt | € 1,011,417 | € 1,296,101 | € 795,902 | € 624,218 | ▼ 22% |
| Balance sheet total | € 7,006,517 | € 7,215,262 | € 7,104,300 | € 6,609,413 | ▼ 7% |
| Employees (FTE) | 23 | 24.8 | 25.7 | 25.5 | ▼ 0.2 |
Key figures of Diagnosecentrum Noord-Limburg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Diagnosecentrum Noord-Limburg?
What happened at Diagnosecentrum Noord-Limburg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- mThe Consult BV stepped down as director. NBB
- Theodoor Vansummeren stepped down as director. NBB
- Ivo Geenen stepped down as director. NBB
- Bart Mandervelt stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 230,370 (▲ 35% vs 2024). Source: NBB ↗
- Tom Van Bouwel stepped down as director. NBB
- Dirk Vanderhoydonck stepped down as director. NBB
- Pieter Deprez stepped down as director. NBB
In short
From € 39,606 profit in 2022 to € 230,370 profit in 2025.
Paid € 567,958 in corporate taxes since 2022.
Best year ever: 2023, with € 330,460 profit.
On average € 108,400 of value added per employee in 2025.
A new publication or filing at Diagnosecentrum Noord-Limburg? We notify you, reason included.
Follow Diagnosecentrum Noord-LimburgDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of Verani itself.
Directors
According to the 2025 annual accounts
Tom Van Bouwel
Director
since 2023 · until 2026
Ivo Geenen
Director
since 2021 · until 2027
Dirk Vanderhoydonck
Director
Also active at: DE NETEHEIDE, Huisartsenpraktijk De Zorgboom, Dokter Vanderhoydonck Dirk
since 2023 · until 2026
Director · represented by Frank Theunis
since 2019 · until 2028
since 2021 · until 2027
Pieter Deprez
Director
since 2023 · until 2026
Theodoor Vansummeren
Director
since 2019 · until 2028
Establishments
Establishment units
Physical locations of this company
Binnensingel 44
3920 Lommel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0449.839.082
- VAT number
- BE 0449.839.082
- Registered office
- Binnensingel 44, 3920 Lommel
- Names & denominations
- Diagnosecentrum Noord-Limburg
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 31 March 1993
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.